The Laziest 10x-Bagger Pitch Ever *

* Maybe this is clickbait, maybe it's not

There is change in the FDA, in a good way, and this is bullish for Biotech.

The FDA’s reversal on uniQure’s (ticker: QURE) Huntington’s Disease drug shows that the new FDA is pragmatic and embraces common sense (The FDA just agreed that the 3-year data from uniQure’s Phase I/II study would be acceptable as the primary basis of a Biologics License Application (BLA) for the accelerated approval of AMT-130).

We enjoyed a >10x-bagger in QURE calls in September 2025, and now we are sitting on a >2x-bagger in QURE equity (as well as healthy gains in CLPT).

We give thanks more importantly for the Huntington’s Disease community. This is what counts.

We wrote about the setup in QURE in "How to make $1 billion", in what may be the most clickbait-y title ever.

We refrain from investing in Biotech, apart from platform plays like Clearpoint (ticker: CLPT), but we made an exception in QURE, precisely because we were familiar with CLPT as the delivery mechanism.

This is the point in time where we hang our “Biotech hats”, give thanks for the multi-baggers and retire from Biotech … right?

Well, how about …. juuuuust one more?!

Besides, we came up with another great clickbait-y title we want to put to use!

Presenting:

• “THE LAZIEST 10X-BAGGER BIOTECH PITCH EVER!”